Abbott Laboratories (ABT)

$125.00 +0.70 (0.56%)
Market Cap 216.14B
Revenue (ttm) 41.95B
Net Income (ttm) 13.40B
EPS (ttm) N/A
PE Ratio 24.98
Forward PE 22.00
Profit Margin 31.95%
Debt to Equity Ratio 0.25
Volume 7,187,800
Avg Vol 6,115,150
Day's Range N/A - N/A
Shares Out 1.74B
Stochastic %K 39%
Beta 0.72
Analysts Strong Sell
Price Target $146.33

Company Profile

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement th...

Industry: Medical Devices
Sector: Healthcare
Phone: 224 667 6100
Address:
100 Abbott Park Road, Abbott Park, North Chicago, United States
bidBreakzz
bidBreakzz Jan. 14 at 12:42 PM
$PANW $ABT Security meets healthcare stability
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 14 at 10:58 AM
$ABT Share Price: $124.25 Contract Selected: Feb 06, 2026 $125 Calls Buy Zone: $1.89 – $2.33 Target Zone: $3.52 – $4.30 Potential Upside: 76% ROI Time to Expiration: 22 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
FLAFOREVER
FLAFOREVER Jan. 14 at 5:44 AM
$ABT Losing my patience with my 650 shares. Have had it for 4 years and doesn’t do shit.
1 · Reply
TechTraderGrok
TechTraderGrok Jan. 13 at 9:09 PM
Bought $ABT at $124.33. From Grok: "Overbought exhaustion drove CASH exit days ago, but 8% plunge to $188 oversold RSI 60 on profit-taking volume exhausts sellers—new EXAS vote/earnings catalysts flip setup bullish." https://www.techtrader.ai/grokwall/?post=16084&utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
BillionerOfKing
BillionerOfKing Jan. 13 at 5:49 PM
$ABT Current Stock Price: $123.00 Contracts to trade: $125 ABT Jan 16 2026 Call Entry: $0.21 Exit: $0.39 ROI: 85% Hold ~31 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
ST4Life
ST4Life Jan. 13 at 5:35 PM
$ABT Not much to cheer about with ABT these days, used to be a great stock to own.
0 · Reply
WilliamBalding588
WilliamBalding588 Jan. 12 at 6:04 PM
$LNTH $ABT Diagnostics focus
0 · Reply
HelenPace158
HelenPace158 Jan. 12 at 3:06 PM
$ABT $LRCX $SHOP Thoughtfully written
0 · Reply
BlowinMaBackOut
BlowinMaBackOut Jan. 11 at 4:19 PM
$BBNX yes..because $ABT is all about partnering with scams and frauds...lol. Would not be shocked to see some news drop. 📈⏰️
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 8 at 11:41 PM
$ABT Share Price: $126.18 Contract Selected: Jan 30, 2026 $125 Calls Buy Zone: $2.98 – $3.68 Target Zone: $5.35 – $6.54 Potential Upside: 70% ROI Time to Expiration: 21 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Latest News on ABT
Abbott: Not Cheap, But Built To Compound In Uncertain Markets

Jan 7, 2026, 9:17 AM EST - 7 days ago

Abbott: Not Cheap, But Built To Compound In Uncertain Markets

Sentinel Opportunity Fund I Closes Seventh and Eighth Acquisitions with Abbott Laboratories and V3 Engineering, Advancing a Diversified Portfolio Strategy

Jan 7, 2026, 8:00 AM EST - 7 days ago

Sentinel Opportunity Fund I Closes Seventh and Eighth Acquisitions with Abbott Laboratories and V3 Engineering, Advancing a Diversified Portfolio Strategy

Abbott hosts conference call for fourth-quarter earnings

Jan 5, 2026, 4:30 PM EST - 9 days ago

Abbott hosts conference call for fourth-quarter earnings

Abbott's new Libre Assist app feature tackles a top need for people living with diabetes: in-the-moment food decisions

Jan 5, 2026, 9:05 AM EST - 9 days ago

Abbott's new Libre Assist app feature tackles a top need for people living with diabetes: in-the-moment food decisions

Best Dividend Aristocrats For January 2026

Dec 31, 2025, 8:47 AM EST - 14 days ago

Best Dividend Aristocrats For January 2026

ABBV ADM ADP AFL ALB AMCR AOS

Best Dividend Kings: December 2025

Dec 28, 2025, 6:44 AM EST - 17 days ago

Best Dividend Kings: December 2025

ABBV ABM ADM ADP AWR BDX BKH

Chevron, Kimberly-Clark Among 16 Companies To Kick Off 2026 With Annual Dividend Increases In January

Dec 26, 2025, 10:35 PM EST - 19 days ago

Chevron, Kimberly-Clark Among 16 Companies To Kick Off 2026 With Annual Dividend Increases In January

CVX KMB ABM AMGN AVGO BCPC BEN

Abbott Laboratories Shrugs Off Tariffs And China Headwinds With A 7% Dividend Raise

Dec 24, 2025, 10:00 AM EST - 21 days ago

Abbott Laboratories Shrugs Off Tariffs And China Headwinds With A 7% Dividend Raise

Abbott's Volt™ Pulsed Field Ablation System Receives FDA Approval to Treat Patients with Atrial Fibrillation

Dec 22, 2025, 9:00 AM EST - 23 days ago

Abbott's Volt™ Pulsed Field Ablation System Receives FDA Approval to Treat Patients with Atrial Fibrillation

Abbott's Amplatzer Piccolo™ Delivery System Receives FDA Clearance and CE Mark to Optimize Procedures for Premature Babies With a Hole in the Heart

Dec 18, 2025, 9:00 AM EST - 27 days ago

Abbott's Amplatzer Piccolo™ Delivery System Receives FDA Clearance and CE Mark to Optimize Procedures for Premature Babies With a Hole in the Heart

Abbott increases quarterly dividend for 54th consecutive year

Dec 12, 2025, 10:26 AM EST - 4 weeks ago

Abbott increases quarterly dividend for 54th consecutive year

High-Quality Compounders With Both Pricing Power And Idiosyncratic Growth

Dec 11, 2025, 3:45 AM EST - 5 weeks ago

High-Quality Compounders With Both Pricing Power And Idiosyncratic Growth

AI ASND AXON AZO CPRT DXCM HOOD

Abbott's Lingo™ Now on Android™, Expanding Access to Real-Time Glucose Data

Dec 8, 2025, 9:00 AM EST - 5 weeks ago

Abbott's Lingo™ Now on Android™, Expanding Access to Real-Time Glucose Data

University of Wisconsin Wins Abbott and Big Ten's 'We Give Blood' Competition as Campaign Donations Surge 319%, Helping Save Nearly 250,000 Lives

Dec 6, 2025, 8:45 PM EST - 5 weeks ago

University of Wisconsin Wins Abbott and Big Ten's 'We Give Blood' Competition as Campaign Donations Surge 319%, Helping Save Nearly 250,000 Lives

Muscles, the New Flex: Abbott Launches Two New Ensure® Max Protein Shakes to Tap into Growing Muscle Health Movement

Dec 4, 2025, 11:00 AM EST - 5 weeks ago

Muscles, the New Flex: Abbott Launches Two New Ensure® Max Protein Shakes to Tap into Growing Muscle Health Movement

Best Dividend Aristocrats For December 2025

Nov 29, 2025, 8:02 AM EST - 6 weeks ago

Best Dividend Aristocrats For December 2025

ABBV ADM ADP AFL ALB AMCR AOS

Abbott issues US device correction for some glucose monitors over faulty readings risk

Nov 24, 2025, 11:08 AM EST - 7 weeks ago

Abbott issues US device correction for some glucose monitors over faulty readings risk

Exact Sciences Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Exact Sciences Corporation - EXAS

Nov 21, 2025, 8:30 PM EST - 7 weeks ago

Exact Sciences Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Exact Sciences Corporation - EXAS

EXAS

Abbott's $21 Billion Exact Sciences Buyout Reshapes Cancer Diagnostics

Nov 20, 2025, 9:37 AM EST - 7 weeks ago

Abbott's $21 Billion Exact Sciences Buyout Reshapes Cancer Diagnostics

EXAS

Why Abbott is paying $21 billion for Exact Sciences and its Cologuard cancer test

Nov 20, 2025, 8:43 AM EST - 7 weeks ago

Why Abbott is paying $21 billion for Exact Sciences and its Cologuard cancer test

EXAS

Abbott to Acquire Exact Sciences for $21 Billion

Nov 20, 2025, 7:46 AM EST - 7 weeks ago

Abbott to Acquire Exact Sciences for $21 Billion

EXAS

Exact Sciences Stock Soars. Abbott Is Buying It in Deal Valued at $21 Billion.

Nov 20, 2025, 7:46 AM EST - 7 weeks ago

Exact Sciences Stock Soars. Abbott Is Buying It in Deal Valued at $21 Billion.

EXAS

Abbott bolsters diagnostics portfolio with up to $23 billion buyout of Exact Sciences

Nov 20, 2025, 7:36 AM EST - 7 weeks ago

Abbott bolsters diagnostics portfolio with up to $23 billion buyout of Exact Sciences

EXAS

Abbott to acquire Exact Sciences, a leader in large and fast-growing cancer screening and precision oncology diagnostics segments

Nov 20, 2025, 7:30 AM EST - 7 weeks ago

Abbott to acquire Exact Sciences, a leader in large and fast-growing cancer screening and precision oncology diagnostics segments

EXAS

Exact Sciences Stock Jumps on Reported Deal Interest From Abbott Laboratories

Nov 19, 2025, 4:27 PM EST - 2 months ago

Exact Sciences Stock Jumps on Reported Deal Interest From Abbott Laboratories

EXAS

Abbott is weighing takeover of Exact Sciences, Bloomberg News reports

Nov 19, 2025, 1:50 PM EST - 2 months ago

Abbott is weighing takeover of Exact Sciences, Bloomberg News reports

EXAS

Invesco Diversified Dividend Fund Q3 2025 Portfolio Positioning

Nov 12, 2025, 3:58 AM EST - 2 months ago

Invesco Diversified Dividend Fund Q3 2025 Portfolio Positioning

ALC AXP DD KDP KKR MRSH PG

10 Defensive Stocks with Market-Beating Yields

Nov 8, 2025, 1:10 PM EST - 2 months ago

10 Defensive Stocks with Market-Beating Yields

DG

Best Dividend Aristocrats For November 2025

Nov 1, 2025, 10:25 AM EDT - 2 months ago

Best Dividend Aristocrats For November 2025

ABBV ADM ADP AMCR AOS ATO BDX

Abbott Showcases World's First Dual Chamber Leadless Pacemaker in National Media Tour Featuring Patient Story with YourUpdateTV

Oct 30, 2025, 1:00 PM EDT - 2 months ago

Abbott Showcases World's First Dual Chamber Leadless Pacemaker in National Media Tour Featuring Patient Story with YourUpdateTV

Best Dividend Kings: October 2025

Oct 29, 2025, 5:11 AM EDT - 2 months ago

Best Dividend Kings: October 2025

ABBV ABM ADM ADP AWR BDX BKH

Walmart to be first US retailer to sell Abbott's continuous glucose monitor, Axios reports

Oct 21, 2025, 7:34 AM EDT - 3 months ago

Walmart to be first US retailer to sell Abbott's continuous glucose monitor, Axios reports

WMT

Abbott: GLP-1 Beneficiary - A Dividend Raise May Be Coming

Oct 18, 2025, 9:39 AM EDT - 3 months ago

Abbott: GLP-1 Beneficiary - A Dividend Raise May Be Coming

These Analysts Revise Their Forecasts On Abbott Following Q3 Results

Oct 16, 2025, 12:50 PM EDT - 3 months ago

These Analysts Revise Their Forecasts On Abbott Following Q3 Results

Abbott Laboratories Q3 2025 Earnings: Stable Growth Amid Tariff And China Headwinds

Oct 16, 2025, 11:18 AM EDT - 3 months ago

Abbott Laboratories Q3 2025 Earnings: Stable Growth Amid Tariff And China Headwinds

Gold Gains Over 1%; Abbott Shares Fall After Q3 Results

Oct 15, 2025, 2:20 PM EDT - 3 months ago

Gold Gains Over 1%; Abbott Shares Fall After Q3 Results

Abbott Laboratories (ABT) Q3 2025 Earnings Call Transcript

Oct 15, 2025, 1:36 PM EDT - 3 months ago

Abbott Laboratories (ABT) Q3 2025 Earnings Call Transcript

Abbott Posts Solid Earnings, Adult Nutrition Drives Sales. The Stock Drops Anyway.

Oct 15, 2025, 8:25 AM EDT - 3 months ago

Abbott Posts Solid Earnings, Adult Nutrition Drives Sales. The Stock Drops Anyway.

Abbott Labs Posts Higher Sales, Reaffirms Outlook

Oct 15, 2025, 7:55 AM EDT - 3 months ago

Abbott Labs Posts Higher Sales, Reaffirms Outlook

Abbott posts higher quarterly revenue on strong medical device demand

Oct 15, 2025, 7:36 AM EDT - 3 months ago

Abbott posts higher quarterly revenue on strong medical device demand

Abbott Reports Third-Quarter 2025 Results and Reaffirms Full-Year Guidance

Oct 15, 2025, 7:30 AM EDT - 3 months ago

Abbott Reports Third-Quarter 2025 Results and Reaffirms Full-Year Guidance

Stock Market Today: Nasdaq, Dow Jones Futures Rise, Bank Of America, Morgan Stanley, Abbott In Focus—Analyst Warns US 'Going Broke Slowly'

Oct 15, 2025, 5:59 AM EDT - 3 months ago

Stock Market Today: Nasdaq, Dow Jones Futures Rise, Bank Of America, Morgan Stanley, Abbott In Focus—Analyst Warns US 'Going Broke Slowly'

BAC MS

Abbott Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Oct 13, 2025, 10:56 AM EDT - 3 months ago

Abbott Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Abbott Laboratories: There May Be A Surge Coming Next Week (Earnings Preview)

Oct 9, 2025, 7:37 AM EDT - 3 months ago

Abbott Laboratories: There May Be A Surge Coming Next Week (Earnings Preview)

Ventric Health Appoints Managed Care Veteran Christopher Abbott to Board of Directors

Oct 6, 2025, 8:00 AM EDT - 3 months ago

Ventric Health Appoints Managed Care Veteran Christopher Abbott to Board of Directors

Best Dividend Aristocrats For October 2025

Sep 28, 2025, 1:00 AM EDT - 3 months ago

Best Dividend Aristocrats For October 2025

ADP ATO BDX BEN CAH CHRW CL

Abbott Hosts Conference Call for Third-Quarter Earnings

Sep 24, 2025, 9:00 AM EDT - 4 months ago

Abbott Hosts Conference Call for Third-Quarter Earnings

These Dividend Stocks Have Big Yields and Are Beating the Odds

Sep 23, 2025, 2:47 PM EDT - 4 months ago

These Dividend Stocks Have Big Yields and Are Beating the Odds

ABBV DGRO SDY VIG

Daily Dividend Report: Kroger, TXN, Philip Morris, Abbott, GE

Sep 19, 2025, 2:25 PM EDT - 4 months ago

Daily Dividend Report: Kroger, TXN, Philip Morris, Abbott, GE

GE KR PM

1 Dividend King To Hold And 2 Worth Buying Now

Sep 19, 2025, 12:37 PM EDT - 4 months ago

1 Dividend King To Hold And 2 Worth Buying Now

FRT PPG

bidBreakzz
bidBreakzz Jan. 14 at 12:42 PM
$PANW $ABT Security meets healthcare stability
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 14 at 10:58 AM
$ABT Share Price: $124.25 Contract Selected: Feb 06, 2026 $125 Calls Buy Zone: $1.89 – $2.33 Target Zone: $3.52 – $4.30 Potential Upside: 76% ROI Time to Expiration: 22 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
FLAFOREVER
FLAFOREVER Jan. 14 at 5:44 AM
$ABT Losing my patience with my 650 shares. Have had it for 4 years and doesn’t do shit.
1 · Reply
TechTraderGrok
TechTraderGrok Jan. 13 at 9:09 PM
Bought $ABT at $124.33. From Grok: "Overbought exhaustion drove CASH exit days ago, but 8% plunge to $188 oversold RSI 60 on profit-taking volume exhausts sellers—new EXAS vote/earnings catalysts flip setup bullish." https://www.techtrader.ai/grokwall/?post=16084&utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
BillionerOfKing
BillionerOfKing Jan. 13 at 5:49 PM
$ABT Current Stock Price: $123.00 Contracts to trade: $125 ABT Jan 16 2026 Call Entry: $0.21 Exit: $0.39 ROI: 85% Hold ~31 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
ST4Life
ST4Life Jan. 13 at 5:35 PM
$ABT Not much to cheer about with ABT these days, used to be a great stock to own.
0 · Reply
WilliamBalding588
WilliamBalding588 Jan. 12 at 6:04 PM
$LNTH $ABT Diagnostics focus
0 · Reply
HelenPace158
HelenPace158 Jan. 12 at 3:06 PM
$ABT $LRCX $SHOP Thoughtfully written
0 · Reply
BlowinMaBackOut
BlowinMaBackOut Jan. 11 at 4:19 PM
$BBNX yes..because $ABT is all about partnering with scams and frauds...lol. Would not be shocked to see some news drop. 📈⏰️
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 8 at 11:41 PM
$ABT Share Price: $126.18 Contract Selected: Jan 30, 2026 $125 Calls Buy Zone: $2.98 – $3.68 Target Zone: $5.35 – $6.54 Potential Upside: 70% ROI Time to Expiration: 21 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
finansbull88
finansbull88 Jan. 8 at 12:55 PM
$ABT AMAZING :)
0 · Reply
finansbull88
finansbull88 Jan. 8 at 11:31 AM
$ABT Today's breaking news. Lifecare now has a unique technology platform in implant CGM: combination of dual-cavity, fully integrated wireless implant, reproducible manufacturing and raw data that follows glucose trends is very rare in the industry. The market has never seen a commercial or preclinical implant that meets all these points at the same time. 👉 In short: Lifecare now has a big technological lead over Dexcom / Abbott / Medtronic
0 · Reply
finansbull88
finansbull88 Jan. 8 at 11:11 AM
$ABT Lifecare confirms reproducible implant tracks glucose in vivo Bergen, Norway, 8 January 2026 - Lifecare ASA (LIFE) today announces a major system-level milestone, reporting the first in-vivo confirmation that its fully integrated implantable Continuous Glucose Monitoring (CGM) system functions as intended, using implants from the company's first reproducibly manufactured production batch. The acquisition dream is real these giants don't have this : Abbott / Dexcom / Medtronic missing implant Lifecare has a working solution + IP The market is multi-billion USD ➡️ Lifecare is listed on the Oslo Stock Exchange at only $1.6 million. BUY NOW on the OSLO STOCK EXCHANGE There is at least a 1000% upside after today's announcement https://newsweb.oslobors.no/message/663252
1 · Reply
OMW2Money
OMW2Money Jan. 7 at 8:29 PM
$IHI been waiting on this sector for awhile now, is it time for it to finally make a move? $ABT $ISRG $BSX $EW
1 · Reply
Buylowsellhigh416
Buylowsellhigh416 Jan. 6 at 5:23 PM
$ABT 🥳🏃‍➡️
0 · Reply
shitzushimazu
shitzushimazu Jan. 6 at 3:08 PM
$ABT go abbot go
0 · Reply
JackDarwin
JackDarwin Jan. 6 at 1:11 PM
$ABT Bullish Engulfing Candlestick Pattern
0 · Reply
lextrading
lextrading Jan. 3 at 3:22 AM
$ABT Net income and profit margins have doubled. Revenue steady. Gross, operating and FCF margin steady. https://stockanalysis.com/stocks/abt/financials/?ref=kevinom
0 · Reply
lextrading
lextrading Jan. 3 at 3:20 AM
$ABT One of the biggest cup and handles waiting to be played out.
1 · Reply
JackDarwin
JackDarwin Dec. 31 at 11:03 AM
$ABT Bullish Engulfing Candlestick Pattern
0 · Reply
MaggiePanahon1084
MaggiePanahon1084 Dec. 30 at 3:05 PM
$MCD $ABT $SHOP $C $SHEL Global brands navigating inflation and energy shifts carefully https://howardlindzonanalysis.beehiiv.com/p/the-next-big-market-wave-is-forming-be-early-not-late
0 · Reply
Buylowsellhigh416
Buylowsellhigh416 Dec. 29 at 5:07 PM
$ABT cup&handle forming 🤓 5 years chart 190$
0 · Reply